GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Patanjali Foods Ltd

Patanjali Foods Receives Notice Under Drugs and Magic Remedies Act

REGULATORY ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 09 Jun 2026, 03:52 PM IST  ·  BSE ID: 7cdde4ff-2f61-4048-8d27-c73ef19a0a54
View Original BSE Filing (PDF)
💡
In Simple Terms
The company received a notice questioning advertising claims for one of its juice products, asking for its explanation.
🤖 AI Summary
  • Patanjali Foods received a notice from the Food & Drug Administration, Maharashtra.
  • The notice pertains to promotional and labelling claims for 'Patanjali Karela Jamun Juice'.
  • The authority is assessing claims under the Drugs and Magic Remedies Act, 1954.
  • Company's response is sought regarding potential violations of Sections 3 and 4 of the Act.
🏢 How This Affects the Company
📈
Business Impact
This action could impact the sales and distribution of 'Patanjali Karela Jamun Juice' if product recall or discontinuation is enforced.
💰
Financial Impact
Potential costs associated with product recall, distribution discontinuation, and any future penalties could affect financial performance.
⚙️
Operational Impact
The company may need to adjust marketing strategies, labelling, and potentially halt production or distribution of the affected product.
⚠️
Risk Impact
This introduces regulatory risk related to advertising compliance and potential non-compliance with the Drugs and Magic Remedies Act.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders. Monitor further disclosures from the company.
👤
Who Is Affected
Shareholders are affected by potential impacts on the revenue and reputation of the company arising from the regulatory action.
🔍
Management Signal
The company is responding to regulatory inquiries promptly as per disclosure requirements.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Company's response to the regulatory authority regarding the notice.
Further communication from the Food & Drug Administration on the matter.
Any operational changes implemented for 'Patanjali Karela Jamun Juice'.
MEDIUM RISK Regulatory scrutiny under the Drugs and Magic Remedies Act presents a compliance risk for product advertising and claims.
💡 Investor Takeaway
Patanjali Foods received a notice regarding 'Patanjali Karela Jamun Juice' promotional claims under the Drugs and Magic Remedies Act, 1954; response required, potential recall pending review.
❓ Frequently Asked Questions
What did Patanjali Foods receive from the Food & Drug Administration?
Patanjali Foods received a communication from the Joint Commissioner (Drugs), Food & Drug Administration, Maharashtra State, Nagpur Division.
What is the subject of the notice sent to Patanjali Foods?
The notice relates to certain promotional, labelling, advertising, and marketing representations for the product 'Patanjali Karela Jamun Juice'.
Which act is being invoked in the notice to Patanjali Foods?
The notice is under the provisions of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.
What is the authority examining in the notice?
The authority is examining if claims made in the promotional/labelling representations for 'Patanjali Karela Jamun Juice' fall within diseases specified in the DMR Act.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses free when you sign up

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.

Live IPO, GMP and market updates on Telegram

IPO open and close dates, grey market premium moves, subscription figures, allotment and listing days, and the market updates worth knowing about, posted on the channel as they happen.

Join the channel